arrow
M

Ming Luo

Tianjin Key Laboratory of Digestive Cancer
H指数:18
被引数:2,223

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of atezolizumab and bevacizumab with or without TACE as first-line therapy for unresectable HCC: a multicenter cohort study

阿替利珠单抗和贝伐珠单抗联合或联合TACE作为不可切除性HCC的一线治疗的疗效和安全性:一项多中心队列研究

2025-08-250
PRE
MOF catalysis of FeII-to-FeIII reaction for an ultrafast and one-step generation of the Fe2O3@MOF composite and uranium(VI) reduction by iron(II) under ambient conditions

FeII到FeIII反应的MOF催化,用于在环境条件下通过铁 (II) 超快一步一步生成Fe2O3 @ MOF复合材料和铀 (VI) 还原

2016-01-0146
PRE